Ceng Yixin said that the standing meeting of the State Council this year made clear the requirements of reducing tariffs, speeding up the import and listing of innovative drugs, strengthening the protection of intellectual property, strengthening quality supervision and comprehensive measures to let the masses feel the urgent need to reduce the price of anti-cancer drugs, and reduce the cost of anti-cancer drugs from multiple links and channels. In April 20th, the leaders of the State Council also chaired a special meeting to study and deploy specific measures. The national health and Health Committee, in accordance with the principles of government leading, linkage of policies, and continuous regulation, has made a series of work measures to improve the policy of preventing and protecting anti-cancer drugs on the basis of reducing the tax rate and using the combined measures of centralized purchasing, medical insurance payment, rational drug use and R & D innovation. . We should adhere to the peoples health as the center, with both recent and long-term consideration, to promote the landing and form a synergistic effect. It is beneficial to adhere to the value orientation of the drug clinical center, deepen the structural reform of the supply side of the medicine, improve the vitality of the market, improve the supply of anti-cancer drugs, and reduce the cancer. The burden of the patients charge of medicine and the effect of enlarging the policy of benefiting the people. Ceng Yixin stressed that the recent key work was to start the formal implementation of the zero customs tax on imported drugs in May 1st, to start the negotiations on the centralized procurement and medical insurance access for anti-cancer drugs. For the anti-cancer drugs that have been included in the basic medical insurance drug catalogue, the varieties produced by more than 3 enterprises and more than 3 varieties of production enterprises have passed. Negotiations, matching and other ways to encourage the formation of a unified purchasing price in the country; to organize experts to review and carry out access negotiations for anti cancer drugs that have not been included in medical insurance reimbursement, and to incorporate eligible drugs into the range of medical insurance drugs. Ceng Yixin said that departments should do well in the organization and implementation according to the task division, strengthen policy linkage, refine policy measures, clear work requirements, establish long-term working mechanism, and fully promote the implementation of various work. We should strengthen the policy propaganda, widely publicize the main policies and measures for the supply of anti-cancer drugs and the important significance, do a good job in the scientific work of the clinical use of anti-cancer drugs, actively respond to and properly deal with the problems of the public concern on anti-cancer drugs, and do a comprehensive job for the supply and protection of anti-cancer drugs.